Biotech startups find venture capital hard to come by
| November 5, 2007 |  View for printing |
At a recent meeting of Washington biotech executives and scientists, an entrepreneur addressed the gathering and lamented a local "valley of death" -- a reference to the difficulty that scientists have in finding money to take their ideas from the laboratory to the marketplace.
His concern was not new, but it pointed to a hole in the state's biotech community. Biotech startups, which are heavily capital dependent, need venture capital firms -- with their connections and big pocketbooks -- to finance research and ultimately get products to market.
By JOSEPH TARTAKOFF P-I REPORTER
Full Story: http://seattlepi.nwsource.com/busine ... ?source=rss
No reader comments so far. Be the first to comment by clicking the button below.
Reprinted under the Fair Use doctrine of international copyright law. Full copyright retained by the original publication. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.
